5-HT4 receptor explained

5-Hydroxytryptamine receptor 4 is a protein that in humans is encoded by the HTR4 gene.[1] [2]

Function

This gene is a member of the family of human serotonin receptors, which are G protein-coupled receptors that stimulate cAMP production in response to serotonin (5-hydroxytryptamine). The gene product is a glycosylated transmembrane protein that functions in both the peripheral and central nervous system to modulate the release of various neurotransmitters. Multiple transcript variants encoding proteins with distinct C-terminal sequences have been described, but the full-length nature of some transcript variants has not been determined.[3]

Location

The receptor is located in the alimentary tract, urinary bladder, heart and adrenal gland as well as the central nervous system (CNS).[4] In the CNS the receptor appears in the putamen, caudate nucleus, nucleus accumbens, globus pallidus, and substantia nigra, and to a lesser extent in the neocortex, raphe, pontine nuclei, and some areas of the thalamus.It has not been found in the cerebellum.[5]

Isoforms

Internalization is isoform-specific.[6]

Ligands

Several drugs that act as 5-HT4 selective agonists have recently been introduced into use in both scientific research and clinical medicine. Some drugs that act as 5-HT4 agonists are also active as 5-HT3 antagonists, such as mosapride, metoclopramide, renzapride, and zacopride, and so these compounds cannot be considered highly selective. Research in this area is ongoing.[7] Amongst these agonists prucalopride has >150-fold higher affinity for 5-HT4 receptors than for other receptors.

SB-207,145 radiolabeled with carbon-11 is used as a radioligand for 5-HT4 in positron emission tomography pig[8] and human[9] studies.

Agonists

Antagonists

See also

Further reading

External links

Notes and References

  1. Claeysen S, Faye P, Sebben M, Lemaire S, Bockaert J, Dumuis A, Taviaux S . Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31→q33 by in situ hybridization . Cytogenetics and Cell Genetics . 78 . 2 . 133–4 . December 1997 . 9371406 . 10.1159/000134646 .
  2. Blondel O, Vandecasteele G, Gastineau M, Leclerc S, Dahmoune Y, Langlois M, Fischmeister R . Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium . FEBS Letters . 412 . 3 . 465–74 . August 1997 . 9276448 . 10.1016/S0014-5793(97)00820-X . 23714426 . free .
  3. Web site: Entrez Gene: HTR4 5-hydroxytryptamine (serotonin) receptor 4.
  4. Hegde SS, Eglen RM . Peripheral 5-HT4 receptors . FASEB Journal . 10 . 12 . 1398–407 . October 1996 . 8903510 . 10.1096/fasebj.10.12.8903510 . free . 21596751 .
  5. Varnäs K, Halldin C, Pike VW, Hall H . Distribution of 5-HT4 receptors in the postmortem human brain--an autoradiographic study using [125I]SB 207710 . European Neuropsychopharmacology . 13 . 4 . 228–34 . August 2003 . 12888181 . 10.1016/S0924-977X(03)00009-9 . 27945284 .
  6. Mnie-Filali O, Amraei MG, Benmbarek S, Archer-Lahlou E, Peñas-Cazorla R, Vilaró MT, Boye SM, Piñeyro G . Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B . Cellular Signalling . 22 . 3 . 501–9 . March 2010 . 19922792 . 10.1016/j.cellsig.2009.11.004 .
  7. Pellissier LP, Sallander J, Campillo M, Gaven F, Queffeulou E, Pillot M, Dumuis A, Claeysen S, Bockaert J, Pardo L . Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors . Molecular Pharmacology . 75 . 4 . 982–90 . April 2009 . 19168624 . 10.1124/mol.108.053686 . 17957338 .
  8. Kornum BR, Lind NM, Gillings N, Marner L, Andersen F, Knudsen GM . Evaluation of the novel 5-HT4 receptor PET ligand [11C]SB207145 in the Göttingen minipig . Journal of Cerebral Blood Flow and Metabolism . 29 . 1 . 186–96 . January 2009 . 18797470 . 10.1038/jcbfm.2008.110 . free .
  9. Marner L, Gillings N, Comley RA, Baaré WF, Rabiner EA, Wilson AA, Houle S, Hasselbalch SG, Svarer C, Gunn RN, Laruelle M, Knudsen GM . Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo . Journal of Nuclear Medicine . 50 . 6 . 900–8 . June 2009 . 19470850 . 10.2967/jnumed.108.058552 . free .
  10. Costall B, Naylor RJ . The pharmacology of the 5-HT4 receptor . International Clinical Psychopharmacology . 8 Suppl 2 . Suppl 2 . 11–18 . November 1993 . 8201242 . 10.1097/00004850-199311002-00002 . 36692776 .
  11. Godínez-Chaparro B, Barragán-Iglesias P, Castañeda-Corral G, Rocha-González HI, Granados-Soto V . Role of peripheral 5-HT(4), 5-HT(6), and 5-HT(7) receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia . Pain . 152 . 3 . 687–97 . March 2011 . 21239110 . 10.1016/j.pain.2010.12.020 . 140204185 .
  12. Gale JD, Grossman CJ, Whitehead JW, Oxford AW, Bunce KT, Humphrey PP . GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor . British Journal of Pharmacology . 111 . 1 . 332–8 . January 1994 . 8012715 . 1910004 . 10.1111/j.1476-5381.1994.tb14064.x .
  13. Xu R, Hong J, Morse CL, Pike VW . Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography . Journal of Medicinal Chemistry . 53 . 19 . 7035–47 . October 2010 . 20812727 . 2951497 . 10.1021/jm100668r .
  14. Simmen U, Kelber O, Okpanyi SN, Jaeggi R, Bueter B, Weiser D . 2006. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors . Phytomedicine. 13. Suppl 5. 51–5. 16973340 . 10.1016/j.phymed.2006.03.012.